Furthermore, introduction of breast cancer cells and primary explants into a secondary organ environment led to the passive loss of methylation of the E-cadherin promoter and re-expression of this cell-cell adhesion molecule, demonstrating a mechanism for this reversion of EMT. The gene discussed is CDH1; the disease is breast cancer.